Acetylcholinesterase (AChE) activity is increased within and around amyloid plaques, which are present in Alzheimer's disease (AD) patient's brain. In this study, using cultured retinal cells as a neuronal model, we analyzed the effect of the synthetic peptide Ab 25 Á 35 on the activity of AChE, the degradation enzyme of acetylcholine, as well as the involvement of oxidative stress in this process. The activity of AChE was increased when retinal cells were incubated with Ab 25 Á 35 (25 mM, 24 h) and antioxidants such as a-tocopherol acetate and nitric oxide synthase (NOS) inhibitors were capable of preventing this effect. Despite Ab 25 Á 35 did not affect cell membrane integrity, the redox capacity of cells decreased. The incubation with this amyloidogenic peptide led to an increment of reactive oxygen species formation (20%), of lipid peroxidation (65%), and basal intracellular calcium levels (40%). The data obtained show that the enhancement of AChE activity induced by Ab 25 Á 35 is mediated by oxidative stress, and that vitamin E and NOS inhibitors, by preventing the compromise of the enzyme activity, can have an important role in the maintenance of acetylcholine synaptic levels, thus preventing or improving cognitive and memory functions of AD patients. #
Introduction
The major constituent of senile plaques, occurring in Alzheimer's disease (AD), is amyloid b-peptide (Ab), a 40 Á/42 amino acid peptide, which is a cleaved form of the amyloid precursor protein (APP) (Kang et al., 1987; Tanzi et al., 1988) . Ab seems to play a crucial role in the pathogenesis of AD, however the mechanism and the cellular pathways involved in the neuronal degeneration induced by this peptide are not fully understood. It was demonstrated that above a threshold concentration Ab peptides act as potent neurotoxins both in vitro and in vivo (Pereira et al., 1999; Harkany et al., 1999; Kasa et al., 2000; Zhu et al., 2000) . Accumulating evidence suggests that oxidative stress is involved in the mechanism of Ab-induced neurotoxicity (Behl et al., 1992; Butterfield et al., 1994; Mattson et al., 1995; Bus et al., 1999; Huang et al., 1999; Pereira et al., 1999) .
Besides Ab deposition, selective neuronal loss is another hallmark of AD brains, especially with dysfunction and degeneration of basal forebrain cholinergic neurons, which project to hippocampus and neocortex (Geula and Mesulam, 1994) . However, the cause of the basal forebrain cholinergic neurons vulnerability and its relationship to Ab peptides remains unclear. One of the characteristic changes that occurs in AD is the loss of acetylcholinesterase (AChE) activity, the enzyme responsible for acetylcholine hydrolysis, from both cholinergic and non-cholinergic neurons of the brain (Atack et al., 1983) . However, AChE activity has been shown to be increased within and around amyloid plaques (Ulrich et al., 1990; Morán et al., 1993) , to promote the assembly of amyloid beta-peptides into fibrils (Inestrosa et al., 1996) and to increase the cytotoxicity of these peptides (Alvarez et al., 1998) . These reports suggest that AChE could play a pathogenic role in AD by influencing the process leading to amyloid toxicity.
In this study we assessed AChE activity and the kinetic parameters of the enzyme activity when cells are incubated with Ab 25 Á 35 . Considering that Ab 25 Á 35 is
